Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Product Specification Sheet Product Name Stemgent® Dox Inducible Reprogramming Lentivirus Set: mouse OKSM (conc) Description The Stemgent® Dox Inducible Reprogramming Lentivirus Set: mouse OKSM (conc) contains doxycycline (dox)-inducible lentiviruses capable of expressing one of four mouse transcription factors (Oct4, Sox2, Klf4 or c-Myc) under the control of the doxinducible tetO operator when transduced into mammalian cells. Each unique virus is provided as a VSV-G pseudotyped and concentrated virus stock capable of infecting both dividing and non-dividing cells. The expression of these four transcription factors, along with the reverse tetracycline transcriptional activator (rtTA), has been shown to reprogram a variety of mouse cell types including fibroblasts, B cells, T cells, and neural precursor cells to an embryonic stem (ES) cell-like state known as the induced pluripotent stem (iPS) cell1. Proper isolation and subsequent injection of these iPS cells into blastocysts can generate mice that carry all four inducible viruses, which can be reactivated upon the addition of dox2. The Dox Inducible GFPLentivirus is included as a transduction control. Catalog Number ST000014 Set Contents 100 µl Dox Inducible Reprogramming Lentivirus Mouse Oct4 (conc) (Cat. No. ST070003) 100 µl Dox Inducible Reprogramming Lentivirus Mouse Klf4 (conc) (Cat. No. ST070005) 100 µl Dox Inducible Reprogramming Lentivirus Mouse Sox2 (conc) (Cat. No. ST070002) 100 µl Dox Inducible Reprogramming Lentivirus Mouse c-Myc (conc) (Cat. No. ST070004) 4 x 50 µl lentivirus rtTA (Cat. No. ST070048) 100 µl Dox Inducible Lentivirus GFP (Cat. No. ST070049) Storage and Stability Store at -70°C for up to 3 months. Keep frozen until use. Avoid freeze thaw cycles. Quality Control Viral integration copy number was quantified by transduction of mammalian cells followed by qPCR of the genomic DNA for PBS/psi. Transcription factor protein expression was verified by immunocytochemistry analysis of transduced mammalian cells. Reprogramming was verified by transduction of mouse embryonic fibroblasts, generation of iPS cell colonies, and subsequent colony characterization by immunocytochemistry. Tested to be negative for Mycoplasma sp. by PCR and microbial contamination by a sterility test. Safety Precautions The greatest safety risk associated with viral delivery systems stems from the potential generation of recombinant viruses that are capable of autonomous replication during the packaging process. The Stemgent Reprogramming Lentivirus platform eliminates these hazards by combining a disabled viral genome with a unique manufacturing process. Also, gene functions that facilitate the enclosing of the silencing sequence in a viral capsid (e.g., Gag, Pol, Env) are distributed into multiple helper plasmids (which do not contain significant regions of homology) during packaging. This tactic further minimizes the probability of recombination events that might otherwise generate viruses capable of autonomous replication. With these safety measures in place, the Stemgent Reprogramming Lentivirus particles can be employed in standard Biosafety Level 2 tissue culture facilities and 3050 Spruce Street Saint Louis, Missouri 63103 USA Telephone 800-325-5832 - (314) 771-5765 Fax (314) 286-7828 email: [email protected] sigma-aldrich.com 1 Product Specification Sheet should be treated with the same level of caution as with any other potentially infectious agent. References 1. 2. Brambrink, T., Foreman, R., Welstead, G.G., Lengner, C.J., Wernig, M., Suh, H., and Jaenisch, R. (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151-159. Wernig, M., Lengner, C.J., Hanna, J., Lodato, M.A., Steine, E., Foreman, R., Staerk, J., Markoulaki, S., and Jaenisch, R. (2008) A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 26, 916-924. Restricted Use For restrictions related to the use of this product please refer to the accompanying Restricted Use License. Notice to Purchaser Purchaser represents and warrants that it will use the Stemgent Dox Inducible Reprogramming Lentivirus Set: mouse OKSM (conc) purely for research purposes, not for diagnostic use, not for resale, and not for use in humans or veterinary applications. Stemgent will not be held responsible for patent infringement or other violations that may occur with the use of our products. Stemgent Reprogramming Lentivirus products are sold through Sigma-Aldrich Inc. Sigma-Aldrich Inc. warrants that its products conform to the information contained in this and in other Sigma-Aldrich publications. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Please see the reverse side of the invoice or packing slip. 3050 Spruce Street Saint Louis, Missouri 63103 USA Telephone 800-325-5832 - (314) 771-5765 Fax (314) 286-7828 email: [email protected] sigma-aldrich.com 2